Table 1.
Patients’ clinical characteristics.
| Characteristics | Mean (Range) |
|---|---|
| Age (yr) | 57 (39–86) |
| BMI | 27 (16–32) |
| Histology | Mean (%) |
| HGSC | 161 (100.0) |
| Non-HGSC | 0 (0.0) |
| FIGO stage | Mean (%) |
| IIIC | 47 (29.2) |
| IVA | 76 (47.2) |
| IVB | 38 (23.6) |
| Performance status | |
| 0–1 | 30% |
| 2 | 60% |
| 3 | 10% |
| Regimen of NACT | Mean (%) |
| Taxane + carboplatin | 161 (100.0) |
Data are shown as median (range) or number (%). Abbreviations: HGSC, high grade serous carcinoma; FIGO, International Federation of Gynecology and Obstetrics; NACT, neoadjuvant chemotherapy.